Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.58 USD | -0.29% |
|
-0.37% | -9.37% |
27/06 | Wolfe Research Upgrades Qiagen to Outperform From Peer Perform, Price Target is $50 | MT |
21/06 | Qiagen Seeks M&A | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.37% | 9B | |
+16.59% | 44.44B | |
+42.10% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- QGEN Stock
- News Qiagen N.V.
- Transcript : Qiagen NV Presents at JPMorgan 34th Annual Healthcare Conference, Jan-12-2016 11